Candel Therapeutics director Martine Zimmermann files initial beneficial ownership statement
CADL•Form 3 filing by director
Martine Zimmermann filed an initial Form 3 as a director of Candel Therapeutics on Sept. 8, 2026.
Related News
Galaxy Gaming CFO Steven Kopjo gets $262,500 base pay, 120,000-share option grant in amended employment deal
GLXZ•
Atmos Energy announces R$ 1.72 dividend per unit, payable Sept. 14
ATO•
Los Angeles turns to law firm Susman Godfrey for lawsuit over fire truck prices
OSK•
CPI Card tumbles as PE backer Parallel49 to exit
PMTS•
Applied Materials director Judy Bruner disposes of USD 465,000 in common shares
AMAT•